According to Roche's latest financial reports the company's current earnings (TTM) are $17.67 B. In 2022 the company made an earning of $17.67 B a decrease over its 2021 earnings that were of $19.04 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 | $17.67 B | -7.18% |
2021 | $19.04 B | -6.56% |
2020 | $20.37 B | 18.81% |
2019 | $17.15 B | 19.24% |
2018 | $14.38 B | 14.35% |
2017 | $12.57 B | -1.49% |
2016 | $12.76 B | 5.24% |
2015 | $12.13 B | -4.17% |
2014 | $12.66 B | -23.47% |
2013 | $16.54 B | 22.51% |
2012 | $13.50 B | 6.58% |
2011 | $12.66 B | 5.61% |
2010 | $11.99 B | 21.26% |
2009 | $9.89 B | -27.14% |
2008 | $13.57 B | 0.44% |
2007 | $13.51 B | 30.67% |
2006 | $10.34 B | 51.83% |
2005 | $6.81 B | -18.07% |
2004 | $8.31 B | 110.7% |
2003 | $3.94 B | -210.93% |
2002 | -$3.56 B | -167.07% |
2001 | $5.30 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $24.83 B | 40.53% | ๐บ๐ธ USA |
![]() Novartis NVS | $9.16 B | -48.12% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $24.22 B | 37.05% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $6.27 B | -64.49% | ๐บ๐ธ USA |
![]() Amgen AMGN | $9.19 B | -47.97% | ๐บ๐ธ USA |
![]() Sanofi SNY | $9.96 B | -43.63% | ๐ซ๐ท France |
![]() Becton Dickinson BDX | $1.80 B | -89.80% | ๐บ๐ธ USA |
![]() Merck MRK | $6.38 B | -63.86% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $7.96 B | -54.91% | ๐ฌ๐ง UK |